e in credit f=els limited. Therefore I would like to selectively add some equity=exposure with names that have underperformed the broader market yet mainta=n some buffers to protect us on the downside. =OD We recently added Merck to our =ocus list. I think we should consider a Market Plus Note on MRK (Ov